Investigational. In clinical development, not approved. Material sold as a research chemical is not the trial drug. Educational only — not medical advice.
What it is
Orforglipron is an oral, small-molecule GLP-1 receptor agonist — notable because it is not a peptide and does not require injection or the special formulation oral semaglutide needs.
Proposed mechanism
It activates the same GLP-1 receptor (a class B GPCR) as injectable GLP-1 drugs, but as a small molecule it can be taken as a simple pill.1
State of the evidence
Phase 3 program underway with strong Phase 2 data; not yet approved.
For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.